Sign in

    Eve Bernstein

    Research Analyst at Bernstein Research

    Eve Burstein is Vice President and Senior Research Analyst at AB Bernstein, specializing in US life science tools and diagnostics, where she covers leading companies within these sectors and delivers deeply analytical investment research. She is recognized for her strong track record in market research and data analysis, having previously driven strategic outcomes as an Engagement Manager at McKinsey & Company and advanced cancer research at Memorial Sloan-Kettering Cancer Center. Since joining Bernstein in 2022, Burstein has been instrumental in shaping industry perspectives, leveraging her background in both healthcare management and consulting to provide clients with unique, data-driven insights. She holds advanced professional credentials in life sciences and analytics, with a career rooted in both academic research and institutional finance.

    Eve Bernstein's questions to AGILENT TECHNOLOGIES (A) leadership

    Eve Bernstein's questions to AGILENT TECHNOLOGIES (A) leadership • Q1 2025

    Question

    Eve Bernstein asked how the softness in the academic and government market was trending into February. She also inquired about the potential for a replacement up-cycle in the GC instrument market.

    Answer

    CFO Bob McMahon responded that the trend in February was not materially different from January and that the wider Q2 guidance range reflects this prudence. Regarding GCs, President of the Applied Markets Group Mike Zhang stated that a recently introduced new GC/MS is seeing a very strong customer response, making them optimistic about the long-term replacement opportunity.

    Ask Fintool Equity Research AI